Similar Articles
1231 Targeting the insulin-like growth factor pathway in hepatocellular carcinoma
1232 Hepatitis B and liver transplantation: Molecular and clinical features that influence recurrence and outcome
1233 Recent advances in the surgical treatment of hepatocellular carcinoma
1234 Predictors of recurrence of Crohn’s disease after ileocolectomy: A review
1235 Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma
1236 Interventional treatment for unresectable hepatocellular carcinoma
1237 Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation
1238 Novel approach to identifying the hepatitis B virus pre-S deletions associated with hepatocellular carcinoma
1239 Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors
1240 Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA